⚡RxMarginNADAC StudioFree Interactive Studio
⚔️ vs PioneerRx

RxMarginNADAC Studio — Free Interactive In-Browser Studio

🛡️ 100% ON-DEVICE STUDIO · ZERO CLOUD UPLOAD

Interactive Local Processing Studio

Instant 50ms preview directly in your browser. Zero server queues, zero data leaks.

Quick Scenarios (Click to Switch Mode):
📥
Step 1 · ImportUp to 50MB Local

Drop Local File Here or Click to Browse

Supports CSV, JSON, TXT, XML & Log Streams

🎛️ Step 2 · Tune Parameters50ms Live Sync
70%
Live Visual Inspection Stage
70% Free / 30% Pro

📊 Step 4 · Processed Output

✓
FREE CLEAN
✓
FREE CLEAN
🔒[PROTECTED PRO ROW] Full_Export
🛡️ 100% Local Privacy

Zero Cloud Upload Guarantee

All files and records are processed strictly inside your browser memory. Nothing ever touches an external server.

⚡ Instant 70% Free Preview

Verify Results Before Paying

Test with built-in sample records or drop your own local file to inspect 70% of the processed output free of charge.

💎 Uncapped Commercial Pro

Unlock 100% Export & Offline App

Remove the 30% batch lock immediately with a €3.99 Single Pass or $19 Lifetime Buyout (includes standalone Offline PRO Workstation & Manual).

Quick Reference & Frequently Asked Questions

Why do independent pharmacies lose money filling brand-name GLP-1 prescriptions (Ozempic, Mounjaro, Wegovy)?

Many commercial and Medicare Part D PBM contracts reimburse brand medications at AWP minus 24% to 26.5%, whereas wholesale acquisition cost (WAC minus ~3.5% prompt-pay discount) equals roughly AWP minus 19.6%. That 5%–6% gap translates to a -$30 to -$55 cash loss on every $950 pen dispensed.

How do brand GLP-1 fills hurt my wholesaler generic rebates?

Wholesaler generic rebate matrices (McKesson OneStop, Cardinal SOURCE, Cencora PRxO) tier your generic rebate percentage based on your Generic Compliance Ratio (Generic Purchases ÷ Total Rx Purchases). Adding $150,000/month in brand GLP-1 purchases dilutes your GCR percentage and can trigger a 2%–4% rebate drop across all generics.

What happened to retroactive pharmacy DIR fees after the 2024 CMS reform?

CMS eliminated retroactive Part D pharmacy DIR clawbacks by moving price concessions to the Point of Sale (POS)—resulting in lower upfront AWP/NADAC reimbursement rates at adjudication, while commercial PBMs continue to enforce Generic Effective Rate (GER) and Brand Effective Rate (BER) contract true-ups.

What is the true cost to dispense a single prescription in an independent pharmacy?

When you divide total pharmacy operating overhead (pharmacist and technician salaries, vials/caps, PMS software, E&O insurance, and rent) by annual scripts filled, NCPA Digest data places average cost-to-dispense between $11.80 and $13.50 per prescription.